搜索结果61-70 的 6459 / ◐자부심 있는◑신길동오피● YEOTOP2.COM ● 신길동오피Ⅱ신길동마사지た신길동스파✃신길동안마㈜신길동풀싸롱✢신길동키스방

  1. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood, urine, saliva) and uncover the molecular histone ( ...

  2. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  3. 神经科- 临床试验- 妙佑医疗国际

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect.

  4. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood, urine, saliva) and uncover the molecular histone ( ...

  5. 神经科- 临床试验- 妙佑医疗国际

    ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. Brain Health and Dementia Prevention ...

  6. 神经科- 临床试验- 妙佑医疗国际

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect.

  7. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  8. 神经科- 临床试验- 妙佑医疗国际

    Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl ...

  9. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

  10. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...